JPH0472829B2 - - Google Patents

Info

Publication number
JPH0472829B2
JPH0472829B2 JP59053683A JP5368384A JPH0472829B2 JP H0472829 B2 JPH0472829 B2 JP H0472829B2 JP 59053683 A JP59053683 A JP 59053683A JP 5368384 A JP5368384 A JP 5368384A JP H0472829 B2 JPH0472829 B2 JP H0472829B2
Authority
JP
Japan
Prior art keywords
formula
group
pharmaceutically acceptable
alkyl
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59053683A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59184162A (ja
Inventor
Jeemuzu Re Kaunto Deuitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of JPS59184162A publication Critical patent/JPS59184162A/ja
Publication of JPH0472829B2 publication Critical patent/JPH0472829B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP59053683A 1983-03-29 1984-03-22 キノリン誘導体、その製造法及び該化合物を含有する、５―ヒドロキシトリプタミン桔抗質として使用する医薬組成物 Granted JPS59184162A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8308601 1983-03-29
GB838308601A GB8308601D0 (en) 1983-03-29 1983-03-29 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
JPS59184162A JPS59184162A (ja) 1984-10-19
JPH0472829B2 true JPH0472829B2 (OSRAM) 1992-11-19

Family

ID=10540405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59053683A Granted JPS59184162A (ja) 1983-03-29 1984-03-22 キノリン誘導体、その製造法及び該化合物を含有する、５―ヒドロキシトリプタミン桔抗質として使用する医薬組成物

Country Status (9)

Country Link
US (1) US4576953A (OSRAM)
EP (1) EP0124208B1 (OSRAM)
JP (1) JPS59184162A (OSRAM)
AT (1) ATE33640T1 (OSRAM)
CA (1) CA1258858A (OSRAM)
DE (1) DE3470537D1 (OSRAM)
ES (1) ES8506632A1 (OSRAM)
GB (1) GB8308601D0 (OSRAM)
GR (1) GR79783B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69016125T2 (de) * 1989-08-11 1995-06-01 Zeneca Ltd Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
GB9025123D0 (en) * 1990-11-19 1991-01-02 Ici Plc Nitrogen compounds
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
FR2795645B1 (fr) 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
MY120631A (en) * 2000-09-08 2005-11-30 Union Pharma Scient Appl Novel pharmaceutical combination having analgesic activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
GB1511390A (en) * 1975-12-04 1978-05-17 Pfizer Ltd Imidazolylalkyl sulphide antifungal agents
IN158970B (OSRAM) * 1981-06-09 1987-02-28 Ici Plc
ATE27152T1 (de) * 1982-04-07 1987-05-15 Ici Plc Chinolin-derivate.
EP0093521B1 (en) * 1982-05-04 1988-08-24 Imperial Chemical Industries Plc Quinoline derivatives

Also Published As

Publication number Publication date
ES531099A0 (es) 1985-07-16
ES8506632A1 (es) 1985-07-16
EP0124208A1 (en) 1984-11-07
ATE33640T1 (de) 1988-05-15
GR79783B (OSRAM) 1984-10-31
US4576953A (en) 1986-03-18
CA1258858A (en) 1989-08-29
EP0124208B1 (en) 1988-04-20
DE3470537D1 (en) 1988-05-26
JPS59184162A (ja) 1984-10-19
GB8308601D0 (en) 1983-05-05

Similar Documents

Publication Publication Date Title
KR880001315B1 (ko) 4-아미노-6, 7-디메톡시퀴놀린 유도체의 제조방법
EP0066993B1 (en) Quinoline derivatives
EP1412332B1 (en) Quinoline derivatives and use thereof as antitumor agents
AU2002355747A1 (en) Quinoline derivatives and use thereof as antitumor agents
JPH0472829B2 (OSRAM)
NO831562L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive kinolinderivater
JP2002532494A (ja) パロキセチンの誘導体
US4607040A (en) Quinoline derivatives which are 5-hydroxytryptamine antagonists
JP2002501920A (ja) セロトニン−１ａ受容体作動薬としてのオキサゾール誘導体
JP2009509997A (ja) Ｃｂ２受容体結合能を有する新規なキノリン化合物
US20110059019A1 (en) Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
EP2081907B1 (en) Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
KR100854481B1 (ko) 피페라진일카르보닐퀴놀린 및 ­이소퀴놀린
JPS61158980A (ja) ８α‐アシルアミノエルゴリン類、その製法および医薬組成物
JP2006502171A (ja) アロイル−ピペリジン誘導体
JPH0920758A (ja) 新規環状ジアミン誘導体及びその製造法
JP2002504125A (ja) ドーパミンｄ▲下４▼リガンドとしての２−アミノアルキルアミノキノリン
JP2002511451A (ja) アザシクロアルカン誘導体、その製造及び治療上の使用
JPS5822478B2 (ja) アルキルスルホニルフエノキシプロパノ−ルアミン類
US20060223824A1 (en) Serotonergic agents
AU2008201341B2 (en) Quinoline derivatives and use thereof as antitumor agents
PT94950A (pt) Processo para a preparacao de derivados benzopiranos
JPS58213761A (ja) キノリン誘導体、その製造法及び該化合物を含有する、５−ヒドロキシトリプタミン拮抗作用を有する医薬品
JPH10506095A (ja) 平滑筋弛緩薬としての（３，４−ジオキソシクロブテン−１−イル）クロメン、インデンおよびジヒドロナフタレノン誘導体
CA2392149A1 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof